European Healthcare Analysts hold a conference call with management to discuss the near-term growth drivers of Novartis’ blockbuster cardio-renal franchise and the longer-term potential pipeline opportunities on September 4 at 9 am hosted by Jefferies. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVS:
- Biden unveils first 10 drugs subject to Medicare price negotiation
- Novartis presents new long-term Leqvio data
- Novartis’ (NYSE:NVS) Sandoz Bags FDA Approval for Multiple Sclerosis Treatment
- Novartis’ Sandoz receives FDA approval for Tyruko biosimilar for MS
- CVS Unveils Cordavis to Offer Biosimilars. Should AbbVie (NYSE:ABBV) Worry?